291 related articles for article (PubMed ID: 17389057)
21. Molecular clues to pathogenesis in prion diseases.
Laurent M; Johannin G
Histol Histopathol; 1997 Apr; 12(2):583-94. PubMed ID: 9151145
[TBL] [Abstract][Full Text] [Related]
22. Insights into the physiological function of cellular prion protein.
Martins VR; Mercadante AF; Cabral AL; Freitas AR; Castro RM
Braz J Med Biol Res; 2001 May; 34(5):585-95. PubMed ID: 11323744
[TBL] [Abstract][Full Text] [Related]
23. Prion and prejudice: normal protein and the synapse.
Brown DR
Trends Neurosci; 2001 Feb; 24(2):85-90. PubMed ID: 11164938
[TBL] [Abstract][Full Text] [Related]
24. Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence.
Brown DR
Folia Neuropathol; 2005; 43(4):229-43. PubMed ID: 16416388
[TBL] [Abstract][Full Text] [Related]
25. Prion diseases and the 'protein only' hypothesis: a theoretical dynamic study.
Laurent M
Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):35-9. PubMed ID: 8761449
[TBL] [Abstract][Full Text] [Related]
26. Low copper and high manganese levels in prion protein plaques.
Johnson CJ; Gilbert PU; Abrecht M; Baldwin KL; Russell RE; Pedersen JA; Aiken JM; McKenzie D
Viruses; 2013 Feb; 5(2):654-62. PubMed ID: 23435237
[TBL] [Abstract][Full Text] [Related]
27. Does an ultra violet photooxidation of the manganese-loaded/copper-depleted prion protein in the retina initiate the pathogenesis of TSE?
Purdey M
Med Hypotheses; 2001 Jul; 57(1):29-45. PubMed ID: 11421622
[TBL] [Abstract][Full Text] [Related]
28. Prion protein protects against zinc-mediated cytotoxicity by modifying intracellular exchangeable zinc and inducing metallothionein expression.
Rachidi W; Chimienti F; Aouffen M; Senator A; Guiraud P; Seve M; Favier A
J Trace Elem Med Biol; 2009; 23(3):214-23. PubMed ID: 19486831
[TBL] [Abstract][Full Text] [Related]
29. [Transmissible spongiform encephalopathies (prion diseases)--molecular principles and in vitro models].
Kretzschmar H
Wien Med Wochenschr; 1998; 148(4):67-73. PubMed ID: 9611345
[TBL] [Abstract][Full Text] [Related]
30. Cell culture models of transmissible spongiform encephalopathies.
Béranger F; Mangé A; Solassol J; Lehmann S
Biochem Biophys Res Commun; 2001 Nov; 289(2):311-6. PubMed ID: 11716473
[TBL] [Abstract][Full Text] [Related]
31. Structuring the puzzle of prion propagation.
Eghiaian F
Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
[TBL] [Abstract][Full Text] [Related]
32. The cellular prion protein binds copper in vivo.
Brown DR; Qin K; Herms JW; Madlung A; Manson J; Strome R; Fraser PE; Kruck T; von Bohlen A; Schulz-Schaeffer W; Giese A; Westaway D; Kretzschmar H
Nature; 1997 Dec 18-25; 390(6661):684-7. PubMed ID: 9414160
[TBL] [Abstract][Full Text] [Related]
33. Trafficking of the cellular isoform of the prion protein.
Lehmann S; Milhavet O; Mangé A
Biomed Pharmacother; 1999; 53(1):39-46. PubMed ID: 10221167
[TBL] [Abstract][Full Text] [Related]
34. Prion diseases: dynamics of the infection and properties of the bistable transition.
Kellershohn N; Laurent M
Biophys J; 2001 Nov; 81(5):2517-29. PubMed ID: 11606267
[TBL] [Abstract][Full Text] [Related]
35. Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies.
Buchholz CJ; Bach P; Nikles D; Kalinke U
Expert Opin Biol Ther; 2006 Mar; 6(3):293-300. PubMed ID: 16503737
[TBL] [Abstract][Full Text] [Related]
36. Prion channel proteins and their role in vacuolation and neurodegenerative diseases.
Kourie JI
Eur Biophys J; 2002 Sep; 31(5):409-16. PubMed ID: 12202918
[TBL] [Abstract][Full Text] [Related]
37. Physiopathologic implications of the structural and functional domains of the prion protein.
Sorgato MC; Bertoli A
Ital J Biochem; 2006; 55(3-4):222-31. PubMed ID: 17274528
[TBL] [Abstract][Full Text] [Related]
38. The cellular prion protein: biochemistry, topology, and physiologic functions.
Griffoni C; Toni M; Spisni E; Bianco M; Santi S; Riccio M; Tomasi V
Cell Biochem Biophys; 2003; 38(3):287-304. PubMed ID: 12794269
[TBL] [Abstract][Full Text] [Related]
39. Structural characterization of beta-sheeted oligomers formed on the pathway of oxidative prion protein aggregation in vitro.
Redecke L; von Bergen M; Clos J; Konarev PV; Svergun DI; Fittschen UE; Broekaert JA; Bruns O; Georgieva D; Mandelkow E; Genov N; Betzel C
J Struct Biol; 2007 Feb; 157(2):308-20. PubMed ID: 17023178
[TBL] [Abstract][Full Text] [Related]
40. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles.
Alais S; Simoes S; Baas D; Lehmann S; Raposo G; Darlix JL; Leblanc P
Biol Cell; 2008 Oct; 100(10):603-15. PubMed ID: 18422484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
